Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

RSS icon

Edwards Lifesciences Reports Second Quarter Results

Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today reported net income for the quarter ended June 30, 2015 of $112.7 million, or $1.02 per diluted share. 

New release of CAAS IntraVascular for analysis of IVUS, NIRS-IVUS and OCT datasets

Pie Medical Imaging announces the release of CAAS IntraVascular 2.0, the dedicated software for analysis of IVUS, NIRS-IVUS and OCT datasets.

Siemens Healthcare Diagnostics introduces portable coagulation analyser for fast and reliable testing at the point of care

Siemens Healthcare Diagnostics has launched the hand-held and portable Xprecia Stride Coagulation Analyser to deliver fast, reliable testing in any clinical environment. 

Vital’s CT Myocardial Perfusion to Make Its U.S. Debut at SCCT 2015

Vital Images, Inc. (Vital) will debut its 510(k) FDA-cleared CT Myocardial Perfusion application at the 10 th Annual Scientific Meeting of the Society of Cardiovascular Computed Tomography (SCCT) in Las Vegas, July 16-19. 

Thumbnail

Annual CT scan, ultrasound may be unnecessary after EVAR in some patients

Guidelines from the Society of Vascular Surgery recommend yearly surveillance imaging with CT scanning or ultrasonography after patients undergo endovascular aortic aneurysm repair (EVAR) for abdominal aortic aneurysms (AAA). Still, the frequent use of imaging may not be necessary in some patients, based on results of a study published online in JAMA Surgery on July 8.

Edwards Lifesciences Enters Into Agreement To Acquire CardiAQ

Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that it has agreed to acquire CardiAQ Valve Technologies, Inc., a privately held company and developer of a transcatheter mitral valve replacement system. 

Thumbnail

HRS Doesn’t Miss a Beat with Cutting-edge Trials

The Heart Rhythm Society focused on the latest developments in electrophysiology and the management of patients with rhythm disorders and heart failure at its 2015 meeting on May 13-16 in Boston. The event included 12 late-breaking clinical trials.

Thumbnail

On the QT: EMR Drug Alerts That Physicians Value

Patient safety is a major concern for every health professional. However, for cardiologists, the interaction of certain drugs and heart conditions make vigilance against contraindications and complications an added battle. EMRs can help, but only if they work reliably and clinicians observe alerts.

Displaying 1705 - 1712 of 2645

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.